A new study shows that aberrant DNA transposase activity promotes structural alterations that are clonally selected to drive tumor development. This discovery uncovers novel mechanisms of tumor-suppressor gene inactivation and highlights a new approach to cancer gene identification.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Henssen, A.G. et al. Nat. Genet. 49, 1005–1014 (2017).
Chun, H.J. et al. Cancer Cell 29, 394–406 (2016).
Lee, R.S. et al. J. Clin. Invest. 122, 2983–2988 (2012).
Northcott, P.A. et al. Nature 488, 49–56 (2012).
Mack, S.C. et al. Nature 506, 445–450 (2014).
Molenaar, J.J. et al. Nature 483, 589–593 (2012).
Zhuang, J. & Weng, Z. Nucleic Acids Res. 43, 8146–8156 (2015).
Moncunill, V. et al. Nat. Biotechnol. 32, 1106–1112 (2014).
Huang, F.W. et al. Science 339, 957–959 (2013).
Northcott, P.A. et al. Nature 511, 428–434 (2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Mack, S., Suzuki, H. & Taylor, M. Transposase-driven rearrangements in human tumors. Nat Genet 49, 975–977 (2017). https://doi.org/10.1038/ng.3908
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.3908